Profile data is unavailable for this security.
About the company
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.
- Revenue in HKD (TTM)2.38bn
- Net income in HKD146.94m
- Incorporated1998
- Employees2.59k
- LocationJoinn Laboratories China Co LtdA5 Rongjing East StreetEconomic-Technological Development AreaBEIJING 100176ChinaCHN
- Phone+86 1 067869582
- Fax+86 1 067869966
- Websitehttps://www.joinnlabs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qyuns Therapeutics Co Ltd | 48.31m | -453.64m | 2.89bn | 325.00 | -- | 7.30 | -- | 59.76 | -1.93 | -1.93 | 0.2193 | 1.78 | -- | -- | -- | 145,950.60 | -- | -- | -- | -- | 84.05 | -- | -976.77 | -- | 1.83 | -29.56 | 0.5795 | -- | -- | -- | -70.28 | -- | -- | -- |
| Abbisko Cayman Ltd | 534.81m | -17.42m | 3.02bn | 275.00 | -- | 1.36 | 850.57 | 5.65 | -0.0295 | -0.0295 | 0.8235 | 3.28 | 0.2159 | -- | 65.75 | 2,072,904.00 | -0.7034 | -- | -0.733 | -- | 0.00 | -- | -3.26 | -- | -- | -- | 0.0142 | -- | -- | -- | 12.92 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | 405.46k | -402.65m | 3.17bn | 150.00 | -- | 4.91 | -- | 7,816.15 | -1.12 | -1.12 | 0.0011 | 1.73 | -- | -- | -- | 2,796.26 | -- | -- | -- | -- | -- | -- | -99,307.43 | -- | -- | -- | 0.14 | -- | -28.25 | -- | 5.82 | -- | -- | -- |
| CARsgen Therapeutics Holdings Ltd | 6.82m | -747.33m | 4.17bn | 477.00 | -- | 2.61 | -- | 611.06 | -1.34 | -1.34 | 0.0122 | 2.80 | 0.0027 | -- | 0.302 | 13,214.28 | -29.27 | -- | -32.86 | -- | 25.50 | -- | -10,960.25 | -- | 9.44 | -- | 0.1246 | -- | -- | -- | 16.19 | -- | -- | -- |
| Alphamab Oncology | 275.18m | -231.90m | 4.33bn | 429.00 | -- | 2.48 | -- | 15.74 | -0.2409 | -0.2409 | 0.2858 | 1.82 | 0.1145 | 0.8256 | 13.94 | 632,607.10 | -9.65 | -18.72 | -11.16 | -21.94 | 79.33 | -- | -84.27 | -415.55 | 4.42 | -- | 0.167 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
| Laekna Inc | 0.00 | -317.84m | 4.44bn | 92.00 | -- | 6.10 | -- | -- | -0.8919 | -0.8919 | 0.00 | 1.86 | 0.00 | -- | -- | 0.00 | -31.46 | -- | -35.71 | -- | -- | -- | -- | -- | -- | -- | 0.0856 | -- | -- | -- | 52.81 | -- | -- | -- |
| Lepu Biopharma Co Ltd | 220.56m | -78.10m | 5.53bn | 491.00 | -- | 5.62 | 405.74 | 25.05 | -0.0463 | -0.0463 | 0.1325 | 0.5751 | 0.0847 | 1.86 | 1.53 | 514,131.50 | -3.53 | -- | -5.72 | -- | 78.76 | -- | -41.62 | -- | 0.7322 | -2.71 | 0.4621 | -- | 1,347.16 | -- | 96.79 | -- | -- | -- |
| TYK Medicines Inc | 0.00 | -460.24m | 9.09bn | 144.00 | -- | -- | -- | -- | -1.24 | -1.24 | 0.00 | -3.04 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -50.25 | -- | -- | -100.00 | -- | -22.97 | -- | -- | -- |
| Keymed Biosciences Inc | 87.82m | -799.16m | 11.58bn | 1.12k | -- | 4.08 | -- | 131.88 | -3.06 | -3.06 | 0.3359 | 10.14 | 0.0207 | 0.3115 | 7.74 | 97,900.21 | -18.86 | -- | -20.96 | -- | 68.65 | -- | -909.38 | -- | 4.83 | -- | 0.2155 | -- | 253.87 | -- | -16.63 | -- | -- | -- |
| Ascentage Pharma Group International | 971.19m | -387.48m | 12.94bn | 574.00 | -- | 15.67 | -- | 13.32 | -1.34 | -1.34 | 3.34 | 2.62 | 0.2998 | 3.49 | 2.19 | 1,665,855.00 | -11.97 | -44.93 | -16.78 | -57.04 | 96.96 | 87.68 | -39.93 | -976.10 | 1.83 | -8.16 | 0.6865 | -- | 5.85 | 100.76 | -4.84 | -- | 2.82 | -- |
| Joinn Laboratories China Co Ltd | 2.38bn | 146.94m | 14.27bn | 2.59k | 50.81 | 0.8773 | 49.12 | 5.99 | 0.196 | 0.196 | 3.18 | 11.35 | 0.2227 | 1.45 | 7.65 | 948,554.10 | 1.31 | 8.92 | 1.58 | 11.01 | 33.56 | 46.67 | 5.86 | 32.00 | 3.10 | -- | 0.0071 | 24.51 | 4.78 | 42.20 | -63.04 | 30.36 | 8.21 | -- |
Data as of Nov 14 2024. Currency figures normalised to Joinn Laboratories China Co Ltd's reporting currency: Hong Kong Dollar HKD
